Ben Venue Recalls Midazolam HCl Injection Due to Potential Low Fill Volume
Ben Venue Laboratories is recalling Midazolam HCl Injection vials because some may have low fill volume. The recall covers 11,161 packs distributed nationwide and in Puerto Rico.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a potential dosing error (low fill volume) without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
Ben Venue Laboratories, Inc. is recalling Midazolam HCl Injection, 5 mg/mL, 1 mL single-use vials. The recall involves 11,161 packs, each containing 10 vials. The products are identified by Lot #1856177 and have an expiration date of 06/30/13.
The recall was initiated because there is a potential that vials with low fill volume were released into distribution. This means some vials may not contain the full labeled amount of medication.
The affected products were distributed nationwide and in Puerto Rico. Healthcare providers and pharmacies should stop using the recalled vials and contact the manufacturer for instructions on how to return them.
The recalled product
- Product
- Midazolam HCl Injection, 5 mg/mL, 1 mL single use vials, packaged in 10 x 1 mL single use vials per pack, Rx only, Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; Manufactured for: Bedford Laboratories, Bedford, OH 44146, NDC 55390-138-01; UPC 3 55390-138-01…
- Manufacturer
- Ben Venue Laboratories Inc
- Category
- Drug — Injection
- Hazard
- Affected units
- 11,161
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #1856177
- Exp 06/30/13
Distribution
Part of a larger recall action
This product is one of 2 recalled by Ben Venue Laboratories Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Ben Venue Laboratories Inc
See all →- SevereBen Venue Recalls Cytarabine for Injection Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- CriticalBen Venue Recalls Acetylcysteine Solution Due to Glass Particulate
FDA (Drugs) · 2014-05-28
- ModerateBen Venue Recalls Leucovorin Calcium Injection Due to Particulate Matter
FDA (Drugs) · 2012-11-07
- SevereBen Venue Recalls Vecuronium Bromide Injection Due to Particulate Matter
FDA (Drugs) · 2012-10-03
- ModerateBen Venue Recalls Octreotide Acetate Injection Due to Potential Low Fill Volume
FDA (Drugs) · 2012-06-20
Same hazard · low fill volume
See all →- SevereSanofi Recalls Subpotent Rifadin Rifampin Capsules Due to Low Fill Volume
FDA (Drugs) · 2013-08-14
Similar recalls
- CriticalPharmakon Recalls Midazolam HCl Vials Due to Undeclared Benzyl Alcohol
FDA (Drugs) · 2014-09-03
- SevereFresenius Kabi Recalls Midazolam Injection Due to Impurities
FDA (Drugs) · 2017-02-08
- SevereFresenius Kabi Recalls Midazolam Hydrochloride Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2014-12-17
- ModerateBen Venue Recalls Leucovorin Calcium Injection Due to Particulate Matter
FDA (Drugs) · 2012-11-07
- SevereMidazolam Injectable Recalled for Silicone Particulate Matter Contamination
FDA (Drugs) · 2023-11-29
- SevereBen Venue Recalls Cytarabine for Injection Due to Sterility Concerns
FDA (Drugs) · 2014-08-27